INS and metabolic dysfunction-associated steatotic liver disease: In one study, the prevalence of NAFLD was low in individuals with type 1 diabetes (8.8%) and in those with type 2 diabetes NAFLD prevalence was lower in insulin-treated (61.7%) than in insulin-naive (75.6%) individuals [106].